PHT Corporation's Valdo Arnera, MD Wins Prestigious Lifetime Achievement Award from Good Clinical Practice Journal
General Manager of global ePRO market leader's European Operations honored at 2009 Clinical Research Excellence Awards for life-long commitment to using science to bring new medical solutions
BOSTON, Mass and GENEVA, Switzerland – 21 October 2009 – PHT Corporation announced that last night General Manager of PHT Europe Valdo Arnera, MD, won the prestigious Lifetime Achievement Award at the Good Clinical Practice Journal (GCPj) 2009 Clinical Research Excellence Awards. PHT is the leading provider of ePRO solutions used in pharmaceutical and biotechnology clinical trials worldwide,
GCPj Editor Joanne Payne’s announcement of Dr. Arnera’s award was the highlight of a glittering dinner in London last night. The magazine’s editors and independent industry experts honored individuals and organizations in the pharmaceutical and biotechnology industries for a variety of important achievements in clinical trial management.
Valdo Arnera is a true pioneer in the adoption of electronic diaries for pharmaceutical trials worldwide. He has more than 25 years of experience in the pharmaceutical industry. He is experienced in both science (with a focus on clinical laboratory and Patient Reported Outcomes) and corporate development and management.
In accepting the award, Dr. Arnera said, “Throughout my career I have been committed to using science and technology to improve the way we develop new medical solutions. By honoring me with this esteemed award tonight, you remind us all that together we have the power to improve the health and well-being of our fellow citizens around the world.”
PHT President and CEO Phil Lee said, “Valdo Arnera exemplifies all that is best in the pharmaceutical and biotechnology industries. His steadfast devotion to improving the health of people around the world enables our customers to do better science and improve clinical trial operations. We’re extremely proud that Valdo is a founding member of our PHT team and we offer him congratulations on this tremendous honor.”
About PHT Corporation
PHT is the market-leading provider of electronic patient reported outcome (ePRO) solutions used in more than 400 clinical trials by 100 biopharmaceutical clients. The proven LogPad® System and revolutionary SitePad® Tablet deliver the voice of the patient, in 88 languages, from homes and sites in 65 countries around the world. By capturing high-quality and time-stamped assessments with minimal respondent burden, trial sponsors are able to run smaller and more conclusive clinical research programs resulting in significant R&D cost savings. Real-time study management through PHT StudyWorks™ features eClinical data integration, standard and custom data summaries for compliance and enrollment, SafetyPRO™ email alerts, and the industry’s premier study archive. Patient experiences captured firsthand by PHT’s ePRO Product Suite have been used successfully in at least 12 NDA submissions and seven approvals to date. For more information, review interactive product demonstrations at the award-winning www.phtcorp.com.
PHT, LogPad, eSense, StudyWorks, SafetyPRO and SitePad are among the registered trademarks and trademarks of PHT Corporation.
Contact: Brenda Nashawaty, bnashawaty@phtcorp.com, 617-688-3253
###
